Osamu Sakai1, Hiroka Yamamoto1, Masaya Igase1, Takuya Mizuno2. 1. Laboratory of Molecular Diagnostics and Therapeutics, Joint Graduate school of Veterinary Medicine, Yamaguchi University, Yoshida, Japan. 2. Laboratory of Molecular Diagnostics and Therapeutics, Joint Graduate school of Veterinary Medicine, Yamaguchi University, Yoshida, Japan mizutaku@yamaguchi-u.ac.jp.
Abstract
BACKGROUND/AIM: Chimeric antigen receptor (CAR) T cell therapy targeting CD20 has the potential to become a promising novel treatment for canine B cell lymphoid malignancy. However, the optimal approach for producing potent CAR-T cells with favorable phenotype for dogs remains unknown. In this study, we assessed several culture conditions and their effects on the phenotypic characteristics of CD20-CAR-T cells. MATERIALS AND METHODS: Canine CAR-T cells were generated by incubating with several mitogens in the presence or absence of Akt inhibitor. Gene transduction efficiency and phenotypic characteristics were determined by flow cytometry. RESULTS: Comparison of several kinds of mitogens revealed that stimulation with phytohemagglutinin has high transduction efficacy, whereas stimulation with concanavalin A was superior in memory T cell formation. Akt inhibition at the initial stage of CAR-T production tended to enhance transduction efficiency and memory T cell formation. CONCLUSION: This study provides a significant insight into the understanding of the ex vivo expansion of canine T cells in adoptive immunotherapy. Copyright
BACKGROUND/AIM: Chimeric antigen receptor (CAR) T cell therapy targeting CD20 has the potential to become a promising novel treatment for canine B cell lymphoid malignancy. However, the optimal approach for producing potent CAR-T cells with favorable phenotype for dogs remains unknown. In this study, we assessed several culture conditions and their effects on the phenotypic characteristics of CD20-CAR-T cells. MATERIALS AND METHODS: Canine CAR-T cells were generated by incubating with several mitogens in the presence or absence of Akt inhibitor. Gene transduction efficiency and phenotypic characteristics were determined by flow cytometry. RESULTS: Comparison of several kinds of mitogens revealed that stimulation with phytohemagglutinin has high transduction efficacy, whereas stimulation with concanavalin A was superior in memory T cell formation. Akt inhibition at the initial stage of CAR-T production tended to enhance transduction efficiency and memory T cell formation. CONCLUSION: This study provides a significant insight into the understanding of the ex vivo expansion of canine T cells in adoptive immunotherapy. Copyright
Authors: Michael Kalos; Bruce L Levine; David L Porter; Sharyn Katz; Stephan A Grupp; Adam Bagg; Carl H June Journal: Sci Transl Med Date: 2011-08-10 Impact factor: 17.956
Authors: Cameron J Turtle; Laïla-Aïcha Hanafi; Carolina Berger; Theodore A Gooley; Sindhu Cherian; Michael Hudecek; Daniel Sommermeyer; Katherine Melville; Barbara Pender; Tanya M Budiarto; Emily Robinson; Natalia N Steevens; Colette Chaney; Lorinda Soma; Xueyan Chen; Cecilia Yeung; Brent Wood; Daniel Li; Jianhong Cao; Shelly Heimfeld; Michael C Jensen; Stanley R Riddell; David G Maloney Journal: J Clin Invest Date: 2016-04-25 Impact factor: 14.808
Authors: Stephen J Forman; Xiuli Wang; Ryan Urak; Miriam Walter; Laura Lim; ChingLam W Wong; Lihua E Budde; Sandra Thomas Journal: J Immunother Cancer Date: 2017-03-21 Impact factor: 13.751
Authors: Andrew R Medvec; Christopher Ecker; Hong Kong; Emily A Winters; Joshua Glover; Angel Varela-Rohena; James L Riley Journal: Mol Ther Methods Clin Dev Date: 2017-11-07 Impact factor: 6.698
Authors: Jesús Aguirre-Hernández; Bruce S Milne; Chris Queen; Patricia C M O'Brien; Tess Hoather; Sean Haugland; Malcolm A Ferguson-Smith; Jane M Dobson; David R Sargan Journal: BMC Vet Res Date: 2009-07-31 Impact factor: 2.741
Authors: Charlotte M Mousset; Willemijn Hobo; Yun Ji; Hanny Fredrix; Valeria De Giorgi; Robert D Allison; Michel G D Kester; J H Frederik Falkenburg; Nicolaas P M Schaap; Joop H Jansen; Luca Gattinoni; Harry Dolstra; Anniek B van der Waart Journal: Oncoimmunology Date: 2018-08-06 Impact factor: 8.110